FDA Approval - Search News

FDA approves leucovorin for rare genetic condition

FDA approves new use of synthetic vitamin B9 — but not for autism symptoms

The FDA announced a new approved use for the drug leucovorin, which Trump has touted as a treatment for autism. But the approval is for cerebral folate deficiency.

· 2d

FDA approves generic drug for a rare genetic condition, but not for autism

· 2d · on MSN

US FDA approves leucovorin for rare genetic disorder causing autism-like symptoms

· 1d

FDA won’t endorse Leucovorin for autism

The FDA expanded the use of prescription drug Leucovorin, but said it won’t recommend it for autism.

· 1d

FDA OKs drug for rare brain disorder

· 1d

FDA approves leucovorin for rare genetic condition, but not for autism

Santa Rosa Press Democrat · 1d

FDA finds little evidence that a generic drug can help people with autism

Patients affected by the condition targeted by Tuesday’s approval experience movement disorders, seizures and other neurological problems that can resemble symptoms of autism.

· 1d

RFK Jr.’s Autism Drug Claims Face Pushback From FDA — Report

· 2d

FDA approves generic drug for rare brain disorder but not autism

1don MSN

Hawley introduces bill to strip FDA approval from 'inherently dangerous' abortion pill

Sen. Josh Hawley, R-Mo., introduced a bill to ban the abortion pill mifepristone, calling it "inherently dangerous" and citing research on serious side effects.

GlobalData on MSN

FDA approves GSK’s Wellcovorin for cerebral folate deficiency

FDA worked with GSK to update Wellcovorin labelling for safe, effective use in adult and paediatric CFD-FOLR1 patients.

Fierce Pharma

FDA approves leucovorin for ultrarare cerebral folate deficiency subset without clinical trial

About five months after U.S. Department of Health and Human Services Secretary Robert F. Kennedy Jr. | About five months after U.S. Health Secretary Robert F. Kennedy Jr. touted leucovorin as “an exciting therapy that may benefit large numbers of children who suffer from autism” during a White House press conference,

KTEN

FDA considers closing approval loophole

U.S. Food and Drug Administrator Marty Makary called on the agency to close a loophole for companies often used to secure product approval.

New York Post

Hawley rolls out bill to nix FDA approval for mifepristone, used for almost two-thirds of US abortions

WASHINGTON — Sen. Josh Hawley rolled out long-shot legislation this week to override the Food and Drug Administration’s approval of mifepristone, part of a two-drug regimen responsible for the majority of abortions in the US. Hawley (R-Mo.

AOL

Josh Hawley rolls out bill to nix FDA approval for mifepristone, used for almost two-thirds of US abortions

GlobalData on MSN

BMS gains FDA approval for Sotyktu in psoriatic arthritis treatment

The FDA granted the approval following findings from the pivotal POETYK PsA-I and POETYK PsA-II Phase III studies.

J&J announces Tecvayli-Darzalex combo approval from FDA for multiple myeloma

Johnson & Johnson (J&J) has announced the US Food and Drug Administration (FDA) approval for the combination of Tecvayli (teclistamab-cqyv) and Darzalex Faspro (daratumumab and hyaluronidase-fihj) for adults with relapsed or refractory multiple myeloma (r/r MM).